| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CytRx Corporation (OTCQB: CYTR)
CYTR Technical Analysis
5
| As on 7th Dec 2022 CYTR STOCK Price closed @ 0.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.63 & Strong Sell for SHORT-TERM with Stoploss of 1.10 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYTRSTOCK Price
| Open | 0.16 | Change | Price | % |
| High | 0.18 | 1 Day | 0.02 | 12.50 |
| Low | 0.16 | 1 Week | -0.02 | -10.00 |
| Close | 0.18 | 1 Month | 0.04 | 28.57 |
| Volume | 7653 | 1 Year | -1.82 | -91.00 |
| 52 Week High 3.21 | 52 Week Low 0.08 | ||||
OTCQB USA Most Active Stocks
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| CBDS | 0.10 | 42.86% |
| ABQQ | 0.00 | % |
| EFSH | 0.23 | 0.00% |
| BTCWF | 0.10 | 150.00% |
| BGLC | 0.22 | -18.52% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| CYTR Daily Charts |
CYTR Intraday Charts |
Whats New @ Bazaartrend |
CYTR Free Analysis |
|
|
CYTR Important Levels Intraday
| RESISTANCE | 0.22 |
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.19 |
| SUPPORT | 0.17 |
| SUPPORT | 0.16 |
| SUPPORT | 0.15 |
| SUPPORT | 0.14 |
CYTR Forecast December 2024
| 4th UP Forecast | 0.91 |
| 3rd UP Forecast | 0.68 |
| 2nd UP Forecast | 0.53 |
| 1st UP Forecast | 0.39 |
| 1st DOWN Forecast | -0.03 |
| 2nd DOWN Forecast | -0.17 |
| 3rd DOWN Forecast | -0.32 |
| 4th DOWN Forecast | -0.55 |
CYTR Weekly Forecast
| 4th UP Forecast | 4.86 |
| 3rd UP Forecast | 3.36 |
| 2nd UP Forecast | 2.43 |
| 1st UP Forecast | 1.50 |
| 1st DOWN Forecast | -1.14 |
| 2nd DOWN Forecast | -2.07 |
| 3rd DOWN Forecast | -3.00 |
| 4th DOWN Forecast | -4.50 |
CYTR Forecast2024
| 4th UP Forecast | 9.14 |
| 3rd UP Forecast | 6.27 |
| 2nd UP Forecast | 4.49 |
| 1st UP Forecast | 2.71 |
| 1st DOWN Forecast | -2.35 |
| 2nd DOWN Forecast | -4.13 |
| 3rd DOWN Forecast | -5.91 |
| 4th DOWN Forecast | -8.78 |
CytRx Corporation ( OTCQB USA Symbol : CYTR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYTR Business Profile
CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides ACDx, an albumin companion diagnostic product to identify patients with cancer who are most likely to benefit from treatment with these drug candidates. CytRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California. Address: 11726 San Vicente Boulevard, Los Angeles, CA, United States, 90049
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service